Monitoring postoperative complications in cancer patients with a smart system
Official title: Postoperative Complications in Cancer Patients Monitored With Intelligent Continuous Monitoring System Versus Standard of Care - a Randomized Clinical Trial
Run by Copenhagen University Hospital, Rigshospitalet · NCT06269198 · Data updated 2026-11-12
This study is testing a smart monitoring system that sends alerts about vital signs to see if it helps high-risk cancer patients recover better after surgery compared to regular monitoring.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 504 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Copenhagen, Other (Non US) and 2 other locations) |
| Status | Recruiting |
| Started | October 31, 2023 |
| Main results expected | April 1, 2025 |
| Study ends | April 1, 2027 |
| Registry record updated | January 15, 2025 |
| Trial ID | NCT06269198 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients undergoing elective major abdominal surgery for cancer with an expected postoperative stay of at least two days.
✕Probably not a fit
Patients who are unable to cooperate with study procedures or have cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of an intelligent continuous monitoring system that provides automatic vital sign alerts compared to routine monitoring alone in high-risk postoperative cancer patients. It is a multicenter randomized controlled trial where patients will be assigned to either an intervention group receiving active alerts or a control group with blinded data collection. The study will assess the severity of complications, frequency of serious adverse events, mortality, length of hospital stay, and delays in planned chemotherapy within 30 days post-surgery.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the severity of postoperative complications in cancer patients, leading to improved recovery outcomes.
How similar studies have gone: Other studies utilizing continuous monitoring systems have shown promising results, suggesting that this approach could be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admission for elective major abdominal (gastrointestinal, gynecological, or urological) surgery with the primary aim of radical surgery/removing suspected cancer tissue. * At least two expected postoperative admission days * Laparotomy or laparoscopy procedure estimated to last more than 2 hours. * Co-enrolment of patients in other studies is acceptable but in studies involving interventions which potentially will affect the continuous monitoring of vital signs and/or the primary or secondary outcomes, an assessment of whether these patients can be co-enrolled in the WARD-RCT should be conferred with the WARD RCT steering committee. Exclusion Criteria: * Patient expected not to cooperate with study procedures * Allergy to study materials (silicone, plaster) * Impaired cognitive function (in uncertain cases assessed by a Mini Mental State Examination score \< 24). (Protocol Appendix E) * Patients with a pacemaker or Implantable Cardioverter Defibrillator (ICD) device * Inability to give informed consent * Patients with planned hyperthermic intraperitoneal chemotherapy (HIPEC) procedure or two-stage resections (two-stage hepatectomy, two-stage resection of malignant colorectal obstructions, etc.)
Where it's running
-
Copenhagen University hospital - Rigshospitalet
Copenhagen, Other (Non US), Denmark Recruiting -
Bispebjerg Hospital
Copenhagen, Other (Non US), Denmark Recruiting -
Hvidovre Hospital
Hvidovre, Other (Non US), Denmark Not yet recruiting
Study contacts
- Principal investigator: Jesper Mølgaard, PhD — Copenhagen University Hospital, Rigshospitalet
- Study coordinator: Jesper Mølgaard, PhD
- Email: moelgaard.jesper@gmail.com
- Phone: +4535453545
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Axillary Web Syndrome after Breast Cancer Surgery: Incidence, Risk Factors, and Outcomes
This study tests how often AWS occurs after breast cancer surgery and what factors make it more likely, using a forward-looking approach in women undergoing SLNB or ALND.
-
Intraoperative Warmth and Moisture for VATS: Do Humidified Gases Help After Thoracic Surgery?
This observational study looks at whether using heated, humidified gases during VATS with one-lung ventilation helps reduce lung-related postoperative problems.
-
Predicting liver failure after major liver surgery using CT measurements and vascular shape changes
Doctors are testing whether adding vascular deformation mapping to CT measurements can better predict liver failure after removing a large portion of the liver.
-
Hernia Sac Flap Coverage of Mesh in Complex Bony-Edged Ventral Hernias
We’re testing whether using the patient’s own hernia sac as a living flap underneath the mesh helps healing after complex ventral hernia repair when part of the edge is bone.
-
Timing of Recruitment Maneuver in Robotic Prostate Surgery
This study tests whether doing a recruitment maneuver before or after CO2 insufflation during robotic prostate surgery helps prevent lung problems afterward.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.